The mysterious interstellar object 3I/ATLAS may be seeding the worlds of this solar system with the early stages of life, new ...

Scripps Research scientists have discovered how some tumors endure DNA damage, revealing a potential new way to target them. The DNA inside our cells is constantly exposed to damage, and one of the ...

A research team from Flinders University found that small, circular pieces of genetic material called circular RNAs might ...

Cedars-Sinai scientists have created a new experimental drug called TY1 that helps the body repair damaged DNA and restore ...

Beam Therapeutics Inc. is a Strong Buy with promising trial results, a solid cash runway, and key data updates ahead. Click ...

A Northwestern Medicine study published in the Journal of Clinical Investigation has uncovered a connection between a ...

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

Fusion oncoproteins arise when a gene fuses with another gene and acquires new abilities. Such abilities can include the ...

Industrialized, small batch, and individual RNA therapeutics become practical with “in-a-box” manufacturing technology.

RNA-based medicines are transforming the way we treat disease—offering targeted, precision therapies for conditions ranging ...